Marian Johnson
Gynecologic Oncology · Macon, GANPI 1740579390
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $907 and has fallen 59.4% since, to $368 in 2025. That places this record below the midpoint for gynecologic oncology clinicians in GA, where the typical reported total is $3,080.
Across 89 payments — averaging $34.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tesaro, Inc.$503
- GSK$413
- AstraZeneca$400
- Merck$248
- Axonics, Inc.$158
- Clovis Oncology, Inc.$142
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,98197%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tesaro, Inc. | 8 | $503 |
| GSK | 5 | $413 |
| AstraZeneca | 12 | $400 |
| Merck | 13 | $248 |
| Axonics, Inc. | 4 | $158 |
| Clovis Oncology, Inc. | 4 | $142 |
| Medtronic(2 entities) | 4 | $142 |
| Aroa Biosurgery Incorporated | 1 | $123 |
| Daiichi Sankyo Inc. | 6 | $119 |
| Biotissue Holdings Inc. | 1 | $118 |
| Immunogen, Inc. | 1 | $118 |
| AbbVie | 5 | $106 |
| Eisai Inc. | 4 | $96 |
| Intuitive Surgical | 3 | $57 |
| Seagen Inc. | 2 | $37 |
| Fennec Pharmaceuticals, Inc. | 1 | $28 |
| Organon | 2 | $27 |
| Novartis | 1 | $25 |
| UCB, Inc. | 1 | $23 |
| G1 Therapeutics, Inc. | 1 | $23 |
| Gilead | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $20 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
| Servier Pharmaceuticals LLC | 1 | $16 |
| ADC Therapeutics America, Inc. | 1 | $15 |
| Recordati_rare_diseases_inc. | 1 | $15 |
| EMD Serono, Inc. | 1 | $14 |
| Aspira Women's Health Inc | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,080 in reported general payments places this provider in the 50th percentile of 49 gynecologic oncology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $11,668 |
| Ondansetron Hcl | 14 | $711 |
| Oxycodone Hcl | 70 | $656 |
| Duloxetine Hcl | 14 | $158 |
| Gabapentin | 13 | $122 |
| Alprazolam | 16 | $64 |
| Paroxetine Hcl | 11 | $1 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Macon
- Michael DillonMacon$678
- Younes El-BakriMacon$35
- Alan GordonMacon$30
- James BurkeSavannah$276K
- Benedict BenignoAtlanta$273K
- Sharad GhamandeAugusta$214K
- Ruchi GargNewnan$125K
- Adam PyrzakAtlanta$116K
- Gerald FeuerAtlanta$102K
- Margarett EllisonMoultrie$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.